Clinical Trial Update: Ate-Bev Early Response Prediction Model in Advanced HCC

View source ↗

Summary

This clinical trial update outlines a study to develop an early response prediction model for advanced hepatocellular carcinoma treated with atezolizumab plus b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma, Atezolizumab-bevacizumab | Status: RECRUITING